Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,963
Total Claims
$999K
Drug Cost
894
Beneficiaries
$1,117
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-52%
Opioid rate vs peers
1.1% vs 2.2% avg
-21%
Cost per patient vs peers
$1,117 vs $1,411 avg
-4%
Brand preference vs peers
10.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.1%
Opioid Rate
119
Opioid Claims
$1,298
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,106 claims · $812K
Generic: 9,736 claims · $177K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 94 | $107K |
| Insulin Glargine,hum.Rec.Anlog | 84 | $76K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $65K |
| Rivaroxaban | 36 | $49K |
| Empagliflozin | 23 | $43K |
| Fluticasone/Vilanterol | 33 | $34K |
| Sitagliptin Phosphate | 20 | $34K |
| Insulin Aspart | 27 | $32K |
| Insulin Aspart | 20 | $31K |
| Dulaglutide | 14 | $28K |
| Insulin Lispro | 12 | $27K |
| Insulin Detemir | 15 | $26K |
| Budesonide/Formoterol Fumarate | 25 | $17K |
| Insulin Detemir | 16 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $12K |
Prescribing Profile
Patient Profile
72
Avg Age
57%
Female
1.65
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data